Mercer Global Advisors
VNRX icon

Mercer Global Advisors’s VolitionRx Ltd VNRX Stock Holding History

Mercer Global Advisors’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9 Buy
+7
New +$17 ﹤0.01% 6064

Other funds holding VNRX

WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Mercer Global Advisors's VNRX Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in VolitionRx Ltd (VNRX) in Q2 2026: 7 shares worth $9. The stake represents ﹤0.01% of the portfolio and ranks #6064 among its holdings.

9 funds tracked by Wall St. Rank hold VNRX as of Q2 2026.

  • Mercer Global Advisors held 7 shares of VolitionRx Ltd worth $9 as of Q2 2026.
  • VolitionRx Ltd was a new Mercer Global Advisors position in Q2 2026.
  • VolitionRx Ltd made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #6064 holding.
  • 9 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.